• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 64-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
429-0848519-8/9/1 28-Apr-2011 64AAL20 3008730588 H&L Industrial China
 
UPS-1560408-1/1/1 01-Apr-2011 64GCY07 3003084296 Serral, S.A. de C.V. Mexico
 
UPS-1730972-1/1/1 20-Apr-2011 64GCY07 1000556091 Bayer Mexico S.A. de C.V. Mexico
 
UPS-1763322-9/1/13 20-Apr-2011 64GCY16 3008844469 Beldi Inc Canada
 
UPS-1782809-2/2/1 22-Apr-2011 64GCY27 1000383130 Bayer S.P.A. Italy
 
AEK-8661615-4/1/1 01-Apr-2011 64GCY29 3006382223 Bayer United Kingdom
 
BUP-1525009-8/1/1 21-Apr-2011 64LBY28 3008363931 Perrigo Israel Pharmaceuticals Ltd Israel
 
XXX-0268245-9/1/10 01-Apr-2011 64LCP06 3006475565 Genfar Colombia
 
XXX-0268245-9/1/9 01-Apr-2011 64LCP74 3005400519 Bristol Myers Squibb Ecuador Cia Ltda. Ecuador
 
UPS-1877899-9/1/11 05-Apr-2011 64LCY44 3008853081 Benedetto Margherita Italy
 
XXX-0269840-6/1/1 04-Apr-2011 64LDP06 3005895078 Laboratorios Quimica Son's, S.A. de C.V. Mexico
 
XXX-0268884-5/1/5 13-Apr-2011 64LDY06 3005353047 Unipharm Guatemala C.A. Guatemala
 
XXX-0269435-5/1/3 13-Apr-2011 64LDY19 3005086176 Qualipharma Guatemala
 
M50-0125480-9/1/1/D 14-Apr-2011 64PMK99 3004822182 Sigan Industries Inc Canada
 
M21-0743204-1/1/1 20-Apr-2011 64UAL04 3007522260 Lyka Bdr International Ltd India
 
113-5531146-2/2/1 14-Apr-2011 64VCS05 3006578267 Rohm And Haas S.A.S France
 
UPS-2097317-4/2/1 25-Apr-2011 64XAY11 1000249433 R.P. Scherer Gmbh Germany
 
WJX-0029379-0/1/1/G 05-Apr-2011 64XBJ03 3008739476 Menscience Androceuticals United States
 
WJX-0029379-0/1/1/H 05-Apr-2011 64XBJ03 3008739476 Menscience Androceuticals United States
 
WJX-0029379-0/1/1/I 05-Apr-2011 64XBJ06 3008739476 Menscience Androceuticals United States
 
AV3-0023215-2/1/6/A 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/6/B 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/6/C 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/6/D 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/C 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/D 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/G 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/Q 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/R 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/S 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/2/4/A 13-Apr-2011 64XDJ06 3005474564 Dermalogica Inc United States
 
AV3-0023215-2/1/7/E 13-Apr-2011 64XDL03 3005474564 Dermalogica Inc United States
 
-
-